English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

BACKGROUND: Nevirapine, a NNRTI (non-nucleoside reverse transcriptase inhibitor), is most commonly used as a part of the combination therapy for HIV (human immunodeficiency virus) infection because of its efficacy and good tolerability. But it is the major culprit in causing adverse drug reactions ranging from mild maculopapular rash to severe toxic epidermal necrolysis. AIM: To observe the spectrum of adverse cutaneous reactions to Nevirapine. METHODOLOGY: This is a retrospective study from the year 2006-2013. RESULTS: 120 cases presented with adverse cutaneous reactions to NVP (Nevirapine). Out of 120 patients, females outnumbered males (68:52). Majority of them were in the age group of 31-40 years. 63 (52.5%) patients developed maculopapular rash, 37 (30.8%) cases of SJS/TEN (Steven Johnson Syndrome/Toxic epidermal necrolysis), 13 (10.8%) patients developed diffuse erythema, urticarial rash in 3 (2.5%), angioedema in 3 (2.5%), 1 (0.9%) developed serum sickness like reaction. CONCLUSION: Managing HIV infection is a double edged sword, and the benefits of ART have to be balanced against the risks of drug toxicity.

A Retrospective Study of Spectrum of Nevirapine Induced Cutaneous Drug Reactions in HIV Positive Patients